Emil J Freireich Leukemia Hematology Grand Rounds

---

RSS

Occurs weekly every Wednesday starting on 1/3/2024 at 8:00 AM
Wednesday, January 3, 2024, 8:00 AM - 9:00 AM, Virtual, Houston, TX


AMA PRA Category 1 Credits™ (1.00 hours), Non-Physician Attendance (1.00 hours)

This series will highlight the research taking place while showcasing leaders from our research community, in an effort to remain engaged and inspired to provide excellence in patient care in the field of leukemia.

1. Discuss new therapies with regards to their mechanisms of action, rationale, toxicity and activity in hematological disorder
2. Apply new strategies for treating Acute Lymphocytic Leukemia, Chronic Lymphocytic Leukemia, and other Hematological cancer in practice to improve patient care
3. Assess patient management based on treatment programs/changes in treatment regimens for hematological disorders
4. Discuss patient management with regards to complications of chemotherapy and immunosuppression & strategies to counteract these complications
5. Discuss new knowledge on molecular etiology of leukemia, as it relates to the development of novel therapies

If you are interested in attending this series, contact Shannon Bailey at [email protected].

In support of improving patient care, The University of Texas MD Anderson Cancer Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

View the accessibility policy for The University of Texas M.D Anderson Cancer Center.

 

The University of Texas MD Anderson Cancer Center complies with all requirements of the identified accrediting body  (ACCME, ANCC, ACPE). Disclosure of speakers, faculty members, planning committee members and their commercial relationships will be shared with learners prior to the educational activity.

Mitigation of Relevant Financial Relationships

The University of Texas MD Anderson Cancer Center adheres to the ACCME's Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all financial relationships with ineligible companies (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Date	Empty Column	Title
		No activities are currently published for this month.
No upcoming dates have been setup.